Robert A Ludwick, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 110 Norman Dorminy Dr Ste A, Fitzgerald, GA 31750 Phone: 229-409-0874 Fax: 229-424-7392 |
News Archive
Patient Safety Technologies, Inc. announced today the closing of a $6.0 million private placement financing. The new capital will primarily be used to fund working capital and the continued growth of the Company.
According to a Food and Drug Administration (FDA) advisory committee's (The Oncology Drugs Advisory Committee, or ODAC) recommendation this Tuesday, the marketing approval of the popular breast cancer drug, Avastin or Bevacizumab should be withdrawn.
Barr Pharmaceuticals, Inc. has announced that its subsidiary Barr Laboratories, Inc. has received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Pharmacia and Upjohn Company's Dostinex (cabergoline) tablets, 0.5 mg.
Salix Pharmaceuticals, Ltd. today announced that as of September 30, 2009 Lupin Ltd. granted Salix the exclusive right in the United States to its bioadhesive drug delivery technology for use with rifaximin. Salix and Lupin have entered into a development, commercialization and license agreement under which the two companies will collaborate in the development and commercialization of a product incorporating rifaximin and utilizing Lupin's proprietary technology.
Turn that frown upside-down? Not if you're keen on looking younger, you shouldn't. A new study shows that smiling can make you appear to be two years older than if you wear a poker face.
› Verified 1 days ago